Sophiris Bio (SPHS) Reports Q4 Loss of $0.15
Tweet
Share
E-mailGet Alerts SPHS Hot Sheet
Join SI Premium – FREE
Sophiris Bio (NASDAQ: SPHS) reported Q4 EPS of ($0.15), versus ($0.31) reported last year.
For earnings history and earnings-related data on Sophiris Bio (SPHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
- Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
